230 related articles for article (PubMed ID: 24599678)
1. Possible novel biomarkers of organ involvement in systemic lupus erythematosus.
Su D; Liu R; Li X; Sun L
Clin Rheumatol; 2014 Aug; 33(8):1025-31. PubMed ID: 24599678
[TBL] [Abstract][Full Text] [Related]
2. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
Julkunen H; Ekblom-Kullberg S; Miettinen A
Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
[TBL] [Abstract][Full Text] [Related]
5. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
6. High frequency of concurrent anti-C1q and anti-dsDNA but not anti-C3b antibodies in patients with Lupus Nephritis.
Kianmehr N; Khoshmirsafa M; Shekarabi M; Falak R; Haghighi A; Masoodian M; Seif F; Omidi F; Shirani F; Dadfar N
J Immunoassay Immunochem; 2021 Jul; 42(4):406-423. PubMed ID: 33788670
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus.
Seelen MA; Trouw LA; Daha MR
Curr Opin Nephrol Hypertens; 2003 Nov; 12(6):619-24. PubMed ID: 14564199
[TBL] [Abstract][Full Text] [Related]
9. Anti-dsDNA titre in female systemic lupus erythematosus patients: relation to disease manifestations, damage and antiphospholipid antibodies.
Gheita TA; Abaza NM; Hammam N; Mohamed AAA; El-Gazzar II; Eissa AH
Lupus; 2018 Jun; 27(7):1081-1087. PubMed ID: 29460701
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH
Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384
[TBL] [Abstract][Full Text] [Related]
11. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations.
Gilliam BE; Ombrello AK; Burlingame RW; Pepmueller PH; Moore TL
Semin Arthritis Rheum; 2012 Jun; 41(6):840-8. PubMed ID: 22177108
[TBL] [Abstract][Full Text] [Related]
12. A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients.
Pradhan V; Mahant G; Rajadhyaksha A; Surve P; Rajendran V; Patwardhan M; Nadkarni A; Dighe S; Ghosh K
Rheumatol Int; 2013 May; 33(5):1193-9. PubMed ID: 22971892
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages.
Bizzaro N; Tonutti E; Villalta D; Tampoia M; Tozzoli R
Arch Pathol Lab Med; 2005 Jan; 129(1):61-8. PubMed ID: 15628909
[TBL] [Abstract][Full Text] [Related]
14. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
[TBL] [Abstract][Full Text] [Related]
15. Are serum autoantibodies associated with brain changes in systemic lupus erythematosus? MRI data from the Leiden NP-SLE cohort.
Magro-Checa C; Kumar S; Ramiro S; Beaart-van de Voorde LJ; Eikenboom J; Ronen I; de Bresser J; van Buchem MA; Huizinga TW; Steup-Beekman GM
Lupus; 2019 Jan; 28(1):94-103. PubMed ID: 30526327
[TBL] [Abstract][Full Text] [Related]
16. Phenome-wide association study identifies dsDNA as a driver of major organ involvement in systemic lupus erythematosus.
Barnado A; Carroll RJ; Casey C; Wheless L; Denny JC; Crofford LJ
Lupus; 2019 Jan; 28(1):66-76. PubMed ID: 30477398
[TBL] [Abstract][Full Text] [Related]
17. Study on the correlation between anti-ribosomal P protein antibody and systemic lupus erythematosus.
Wang Y; Luo P; Guo T; Zou L; Shi J; Chen P
Medicine (Baltimore); 2020 May; 99(20):e20192. PubMed ID: 32443340
[TBL] [Abstract][Full Text] [Related]
18. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
[TBL] [Abstract][Full Text] [Related]
19. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P
J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]